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Background: Socioeconomic status (SES) is a strong social determinant of health. There 
remains a limited understanding of the association between SES and COPD prevalence among 
low- and middle-income countries where the majority of COPD-related morbidity and mortality 
occurs. We examined the association between SES and COPD prevalence using data collected 
in Argentina, Bangladesh, Chile, Peru, and Uruguay.
Methods: We compiled lung function, demographic, and SES data from three population-based 
studies for 11,042 participants aged 35–95 years. We used multivariable alternating logistic 
regressions to study the association between COPD prevalence and SES indicators adjusted for 
age, sex, self-reported daily smoking, and biomass fuel smoke exposure. Principal component 
analysis was performed on monthly household income, household size, and education to create 
a composite SES index.
Results: Overall COPD prevalence was 9.2%, ranging from 1.7% to 15.4% across sites. The 
adjusted odds ratio of having COPD was lower for people who completed secondary school 
(odds ratio [OR] =0.73, 95% CI 0.55–0.98) and lower with higher monthly household income 
(OR =0.96 per category, 95% CI 0.93–0.99). When combining SES factors into a composite 
index, we found that the odds of having COPD was greater with lower SES (interquartile 
OR =1.23, 95% CI 1.05–1.43) even after controlling for subject-specific factors and environ-
mental exposures.
Conclusion: In this analysis of multiple population-based studies, lower education, lower 
household income, and lower composite SES index were associated with COPD. Since household 
income may be underestimated in population studies, adding household size and education into 
a composite index may provide a better surrogate for SES.
Keywords: COPD, socioeconomic status, low- and middle-income country
Background
COPD is a preventable and treatable disease defined by airflow obstruction that is not 
fully reversible.1,2 The leading causes of COPD worldwide include tobacco smoking 
and exposure to household air pollution from biomass fuels, although this may change 
with increasing exposure to tobacco smoking particularly among low- and middle-
income countries (LMICs).3 Estimates show that COPD affects 328 million people 
globally, though population-based data examining the prevalence, risk factors, and 
clinical outcomes of COPD are sparse outside high-income countries (HIC).4,5 A few 
population-based studies have been conducted over the last decade that found a wide 
variation in COPD prevalence among populations.5–7
Socioeconomic status (SES) is one of the most powerful determinants of health 
across a range of chronic diseases.8,9 SES is defined as an individual’s social and 
economic standing and serves as proxy for social or economic position or rank 
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in a social group. More than a measure of income, SES 
encompasses several other measures including education, 
occupation, housing, assets, and participation in social 
organization.10,11 While lower SES was found to be associ-
ated with greater COPD morbidity and mortality in HIC, few 
studies have examined the role of low SES in the prevalence 
of COPD among LMICs.12–14 An understanding of the role 
of SES and COPD in LMICs will potentially inform public 
interventions beyond harm reduction, ie, tobacco cessation 
and decreased biomass fuel smoke exposure, toward those 
aimed at disparities in SES.
Factors limiting a comprehensive assessment of the rela-
tionship between SES and COPD in LMICs include the high 
cost of spirometry and limited data from which to analyze 
associations. Here, we describe the relationship between SES 
and COPD prevalence among the ten low- and middle-income 
settings in Argentina, Bangladesh, Chile, Peru, and Uruguay, 
which encompass a diversity of geographies, ethnicity, and 
variations in altitude and degree of urbanization.
Methods
study setting
This study used pooled data from multiple, population-
based studies sponsored by the United States National 
Institutes of Health/National Heart, Lung, and Blood 
Institute and UnitedHealth Chronic Disease Initiative 
(http://www.nhlbi.nih.gov/about/org/globalhealth/centers). 
Specifically, data were compiled from the Pulmonary Risk 
in South America (PRISA) study conducted by the Institute 
for Clinical Effectiveness and Health Policy (IECS) in two 
sites in Argentina (Marcos Paz and Bariloche), one in Chile 
(Temuco), and one in Uruguay (Canelones), the CRONICAS 
Cohort Study in Peru conducted by CRONICAS Centre of 
Excellence for Chronic Diseases at Universidad Peruana 
Cayetano Heredia, and a longitudinal study in Bangladesh 
conducted by the Centre for Control of Chronic Diseases 
at the International Centre for Diarrheal Disease Research, 
Bangladesh (icddr,b), totaling ten settings of diverse 
geography and SES in five LMICs. Both PRISA and 
CRONICAS studies are prospective longitudinal studies 
with multiple years of follow-up that started in 2010.15,16 
The icddr,b conducted a longitudinal study from 2011 to 
2012.17 The overall cohort is a mixture of rural, semiurban, 
and urban populations.15–18
study design
Both PRISA and CRONICAS used age- and sex-stratified 
random sampling, whereas the Bangladesh study used simple 
random sampling of available census data at each site.15–18 
All three studies aimed to enroll between 500 and 1,800 
participants per site. The PRISA study included participants 
aged 45–75 years, whereas the CRONICAS and Bangladesh 
studies enrolled participants $35 years and $40 years of age, 
respectively.15–18 We limited the age range to 35–95 years 
because of the lack of reference equations in older adults.19 
All studies required permanent residency in the sampling 
areas and ability to provide informed consent.15–18 Common 
exclusion criteria for the PRISA and CRONICAS studies 
included anyone who had active pulmonary tuberculosis and 
was pregnant.15,16 Only one person per household was enrolled 
in all studies.15–17 Informed consent was obtained from all 
participants, and all field workers completed confidentiality 
training.15–18 All studies obtained approval from their corre-
sponding local and international internal review boards.15–18
spirometry
Technicians performed spirometry with EasyOne (PRISA and 
Bangladesh) and Easy-On-PC spirometers (CRONICAS), 
both manufactured by ndd Medical Technologies (Zurich, 
Switzerland).15–18 All studies followed standard guidelines 
for the conduct of spirometry.15–18 Post-bronchodilator 
spirometry was conducted 15 minutes after administration 
of inhaled salbutamol in Bangladesh (5 mg via nebulizer) 
and CRONICAS (200 µg via spacer) or albuterol in PRISA 
(200 µg via spacer).16–18 PRISA and CRONICAS conducted 
pre- and post-bronchodilator spirometry on all participants, 
whereas Bangladesh only conducted post-bronchodilator 
spirometry among those who had evidence of obstruction, 
i.e., a post-bronchodilator forced expiratory volume in one 
second (FEV
1
) over forced vital capacity (FVC) ratio less 
than 0.70.17 Methods for collecting other data for these studies 
are described in previous publications.16–18
Definitions
We defined COPD as having a post-bronchodilator FEV
1
/
FVC below the lower limit of normal (5th percentile) of the 
Global Lung Function Initiative (GLI) reference values 
for mixed ethnic populations20 and conducted sensitivity 
analyses using Caucasian reference values. Severe COPD 
was classified as additionally having a post-bronchodilator 
FEV
1
 ,50% predicted.20 For comparability with other 
studies, we also used the FEV
1
/FVC ,0.70 definition for 
COPD. Three main indicators of SES that were commonly 
available across studies were selected for this analysis: 
household size, education, and monthly household income. 
We categorized monthly income into six categories of 
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increasing order at each site; education as below secondary 
school or secondary school and above. Smoking was clas-
sified as daily smoker ($1 cigarettes/day) or not, while bio-
mass fuel smoke exposure was categorized as using biomass 
as a primary source of fuel or not. In sensitivity analyses, we 
categorized smoking as current, former, and never smoking 
and also calculated pack-years of smoking.
Biostatistical methods
This study had two main analytical objectives: to evalu-
ate the association between SES and COPD preva-
lence and to evaluate the association between SES and 
pre-bronchodilator FEV
1
/FVC Z-scores. We limited our 
analysis to pre-bronchodilator FEV
1
/FVC values because 
the Bangladesh study only conducted post-bronchodilator 
spirometry among participants with a pre-bronchodilator 
FEV
1
/FVC of ,0.7. We used multiple variable logistic 
regressions to evaluate the association between each of the 
SES indicators and COPD adjusted for the following a priori 
selected variables: age, sex, and self-reported biomass fuel 
smoke exposure and daily smoking. Principal component 
analysis was then performed on monthly household income, 
household size, and education to create a composite index 
based on the first principal component (proportion of variance 
0.91), which was then included in a multivariable logistic 
regression model adjusted for the following a priori selected 
variables: age, sex, and self-reported biomass fuel smoke 
exposure and daily smoking.21,22 Since there were multiple 
sites in these analyses leading to a nested design of site and 
individual within site, we used alternating logistic regressions 
to account for correlation.23 We scaled the effect of lower 
composite SES index to the interquartile odds ratio (OR), ie, 
we calculated the ratio of odds of COPD between the values 
in the 25th and 75th percentiles of the composite SES index.
We used linear regression to evaluate the association 
between pre-bronchodilator FEV
1
/FVC Z-scores and each SES 
indicator and SES composite index, adjusted for the following 
a priori selected variables: age, sex, and self-reported biomass 
fuel smoke exposure and daily smoking. We used linear mixed-
effects models with a random intercept by site to model hetero-
geneity by site24 and scaled the effect of lower composite SES 
index to the interquartile difference, ie, we calculated absolute 
difference in pre-bronchodilator FEV
1
/FVC Z-scores between 
75th and 25th percentiles of the composite SES index.
For all the abovementioned analyses, we conducted sen-
sitivity analyses by replacing daily smoking with categories 
of smoking history, and also with pack-years of smoking. All 
analyses were performed using R (www.r-project.org).
Results
Participant characteristics
A total of 11,042 participants met inclusion criteria from 
all ten sites: Bariloche (n=1,105), Canelones (n=938), 
Dhaka (n=1,878), Lima (n=997), Marcos Paz (n=1,242), Matlab 
(n=1,846), rural Puno (n=505), Temuco (n=1,063), Tumbes 
(n=958), and urban Puno (n=510). Pre-bronchodilator lung 
function measurements were available for 11,042 individuals. 
Average age was 56.1±10.4 years, with males accounting 
for 45% of the sample. There was incomplete information 
for household size, monthly household income, education, 
or daily smoking in 1,522 participants. There were no dif-
ferences in prevalence of COPD (P=0.34) or sex (P=0.08) 
between participants with and without complete data adjusted 
for site. On average, participants with incomplete data were 
0.9 years older (P,0.01) than those with complete data. The 
interquartile difference for the composite SES index was 2.90 
(25th and 75th percentiles were −1.85 and 1.05, respectively). 
We summarized other sociodemographic and lifestyle char-
acteristics by site (Table 1).
COPD prevalence
Overall prevalence of COPD was 9.2% with a range of 1.7% 
(Tumbes) to 15.4% (Matlab). The prevalence of COPD by 
site and sex is shown in Figure 1. COPD prevalence was 
higher among participants who were identified as daily 
smokers vs nondaily smokers and nonsmokers (18.5% vs 
7.9%), used biomass as a primary source of fuel vs not (12.8% 
vs 7.8%), and males vs females (12.4% vs 6.5%). Severe 
COPD was 1.5% with a range of 0.0% (urban and rural Puno) 
to 2.8% (Matlab). When the fixed cutoff (post-bronchodilator 
FEV
1
/FVC ,0.7) was used, COPD prevalence was 10.9% 




, FVC, and FEV
1
/FVC 
values were 2.34±0.75 L, 3.08±0.94 L, and 0.76±0.09, 
respectively. The distributions of pre-bronchodilator FEV
1
/
FVC Z-score per site are shown in Figure 2. Bariloche, 
Canelones, Marcos Paz, and Temuco had markedly more 
outliers below the zero line than did other sites. Urban Puno 
had the highest average FEV
1
 and FVC at 2.80±0.83 L and 
3.70±1.07 L, respectively, while Dhaka had the lowest at 
1.90±0.57 L and 2.49±0.71 L. Tumbes had the highest mean 
pre-bronchodilator FEV
1
/FVC at 0.79 and 0.81. In Figure 3, 
we show that altitude of residence was associated with a 
higher pre-bronchodilator FEV
1
 (P=0.04) or FVC Z-score 
(P=0.01). On the other hand, there was not a clear relationship 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































socioeconomic status and COPD among lMICs
between pre-bronchodilator FEV
1
/FVC Z-score and altitude 
of residence (P=0.33).
Determinants of COPD
Analysis using multivariable alternating logistic regression 
showed that the odds of having COPD was positively associ-
ated with use of biomass as a primary fuel source for cooking, 
daily smoking, not having completed secondary education, 
lower monthly household income, and older age (Table 2). 
We found a positive association between the odds of COPD 
and a lower SES composite score, with an interquartile OR 
of 1.23 (95% CI 1.05–1.43). In sensitivity analyses, the 
positive association between low SES and COPD remained 
significant (interquartile OR 1.29, 95% CI 1.12–1.50) when 
we used the GLI Caucasian reference population.
In further sensitivity analyses, we analyzed differences 
using pack-years and categories of smoking history (cur-
rent, former, or never smoker) instead of daily smoking 
or not, while adjusting for age, sex, biomass fuel smoke 
exposure, and site. The interquartile OR for SES was 1.20 
(95% CI 1.01–1.41) when using pack-years and 1.18 (95% 
CI 1.03–1.34) when using categories of smoking history. 
These results were very similar to using daily smoking vs not 
(interquartile OR for SES of 1.23, 95% CI 1.05–1.43).
We then plotted the overall sample adjusted ORs (left 
panel) and site-specific heterogeneity in adjusted ORs (right 
panel) for all SES indicators (Figure 4). Adjusted ORs of 
COPD by site were all in the same direction for secondary 
education and in the majority of sites for monthly household 
income (except for Canelones, Temuco, and Tumbes) and for 
the interquartile difference in composite SES index (except 
for Temuco, Tumbes, and Urban Puno).




/FVC Z-scores were associ-
ated with individuals who were daily smokers, used biomass 
as a primary fuel source for cooking, males, the elderly, 
lower than secondary education, and those who had a 
lower monthly household income. Household size was not 
statistically significant (Table 3). A lower SES composite 
index was associated with lower pre-bronchodilator FEV
1
/ 
FVC Z-scores. Specifically, a decrease equal to the inter-
quartile range was associated with a 0.14 lower (95% CI 
0.09–0.19) pre-bronchodilator FEV
1
/FVC Z-score. When 
using the Caucasian reference instead of that of a mixed 
ethnic population, the overall interquartile difference was 
decreased by a similar amount (0.13, 95% CI 0.08–0.18). 
We plotted the overall sample-adjusted differences in FEV
1
/
FVC Z-score (left panel) and site-specific heterogeneity 
(right panel) for all SES indicators (Figure 5). Adjusted 
differences in FEV
1
/FVC Z-score by site were all in the same 
direction for secondary education, for monthly household 
income, and for the interquartile difference in composite 
SES index.
Discussion
In this analysis of multicenter population-based studies, we 
describe the association between SES and COPD among ten 
sites in Argentina, Bangladesh, Chile, Peru, and Uruguay. 
This study is among the largest to examine the association 
between SES and COPD in LMIC settings, pooling data 
from multiple, population-based studies. We found that 
lower education, lower household income, and a lower 
composite SES index were all associated with higher odds 
of having COPD and a lower pre-bronchodilator FEV
1
/FVC 
ratio. As household monthly income may be underestimated 
in study populations, here we describe a composite index 
that may provide a better surrogate for SES in resource-
poor settings. Although the association between SES and 
COPD has been well described in HIC, there is value in 
Figure 1 Prevalence of COPD per city using the lower limit of normal (lln) method 
of diagnosis with global lung Function Initiative (glI) mixed ethnic population, 
presented as overall and stratified by sex.
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population-based studies among LMICs to better understand 
these associations across income settings, identify popula-
tions at risk, and examine SES-attributable risk factors such 
as biomass fuel smoke exposure.8,12,25,26 Moreover, while 
some aspects of SES cannot be modified, eliminating SES 
disparities could not only decrease future COPD prevalence 
but may also have a greater impact on improving COPD 
outcomes than would current medications.8,27
Our study found similar rates of COPD prevalence 
(10.9% with a range from 3.5% to 18.0% among settings 
when using the fixed ratio) compared with other multiregion, 
population-based studies.1,5 The PLATINO study, conducted 
in five urban Latin American cities, had an overall prevalence 
of 14.5% with a range from 7.8% to 19.7%, while the BOLD 
multicenter study found an overall prevalence of 10% with 
a range from 8.5% to 22.2%.1,5 Our study also found that 
SES was inversely related to COPD, consistent with North 
American and European studies that used a range of measures 
(education, income, and deprivation scores) to evaluate SES 
among high-income populations. Specifically, we found a 
25% increase in the odds of COPD between low- and high-
SES quartiles, a modest increase compared with a previous 
review examining COPD and SES across income settings.8 
This effect was mostly consistent across sites. Additionally, 
we found a positive relationship between composite SES 
index and pre-bronchodilator FEV
1
/FVC Z-score (ie, partici-
pants with higher index score had a greater FEV
1
/FVC for 
their age and sex), and these effects were consistent across 
all settings (Figure 5). This measure adds strength to the 
association between SES and COPD since FEV
1
/FVC Z-score 
is a continuous metric that does not need to be dichotomized 
Figure 3 Mean pre-bronchodilator FeV1 and FeV1/FVC Z-score using global lung 
Function Initiative (glI) mixed ethnic population, by elevation in meters and site.
Notes: elevation is in meters on the x-axis with Z-score on the y-axis. City names 
are beside each corresponding point. The lines represent the fitted values of a 
regression line of Z-score by elevation.
Table 2 Unadjusted and adjusted alternating logistic regression models for COPD using the lower limit of normal (lln) method of 
diagnosis with Global Lung Function Initiative (GLI) mixed ethnic population, coefficients reported as odds ratios




OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Monthly household income 
(change per category)
0.93 (0.87, 1.00) 0.04 0.96 (0.93, 0.99) 0.01
Median household size  
(household size ,4 as reference)
1.10 (0.93, 1.32) 0.26 1.08 (0.90, 1.30) 0.42
secondary school or higher 
(below secondary as reference)
0.71 (0.51, 0.98) 0.04 0.73 (0.55, 0.98) 0.04
Composite ses index 
(interquartile difference)
1.23 (1.01, 1.50) 0.04 1.23 (1.05, 1.43) 0.01
age (per decade increase) 1.48 (1.35, 1.62) ,0.001 1.41 (1.31, 1.51) ,0.001 1.43 (1.33, 1.55) ,0.001
Female (male as reference) 0.46 (0.29, 0.72) ,0.001 0.51 (0.34, 0.78) ,0.001 0.54 (0.36, 0.80) 0.002
Daily smokers (nondaily and 
nonsmokers as reference)
2.66 (2.10, 3.37) ,0.001 2.25 (1.74, 2.92) ,0.001 2.25 (1.76, 2.89) ,0.001
Biomass as primary source of fuel 1.73 (1.44, 2.09) ,0.001 1.52 (1.23, 1.89) ,0.001 1.59 (1.31, 1.94) ,0.001
Abbreviations: ses, socioeconomic status; Or, odds ratio.





Figure 4 Odds ratio of COPD by socioeconomic status composite index (ses index), secondary education or higher (below secondary as reference), greater than or equal 
to median household size of 4 (below as reference), and monthly household income (change per category).
Notes: adjusted odds ratios are displayed for the overall sample (left) and for individual sites (right). In the left panel, the square represents the adjusted odds ratio and the 
segments represent 95% CIs. In the right panel, the triangles represent site-specific adjusted odds ratios. For the composite SES index, we calculate the interquartile odds 
ratio of COPD, ie, the ratio of odds of COPD between the 25th vs 75th percentile of the composite ses index.
Abbreviation: ses, socioeconomic status.
Table 3 Unadjusted and adjusted random effects linear regression models for pre-bronchodilator FeV1/FVC Z-score using global lung 
Function Initiative (glI) mixed ethnic population
Variables Unadjusted Adjusted model (individual 
SES indicators)




P-value Difference  
(95% CI)
P-value Difference  
(95% CI)
P-value
Monthly household income 
(change per category)
0.05 (0.03, 0.07) ,0.001 0.04 (0.02, 0.06) ,0.001
Median household size 
(household size ,4 as reference)
0.04 (−0.01, 0.09) 0.13 0.03 (−0.03, 0.08) 0.32
secondary school or higher 
(below secondary as reference)
0.12 (0.17, 0.77) ,0.001 0.10 (0.05, 0.15) ,0.001
Composite ses index 
(interquartile difference)
−0.15 (−0.16, −0.13) ,0.001 −0.14 (−0.09, −0.19) ,0.001
age (per decade increase) −0.08 (−0.11, −0.06) ,0.001 −0.07 (−0.09, −0.05) ,0.001 −0.08 (−0.10, −0.06) ,0.001
Female (male as reference) 0.19 (0.14, 0.23) ,0.001 0.18 (0.13, 0.23) ,0.001 0.17 (0.12, 0.21) ,0.001
Daily smokers (nondaily and 
nonsmokers as reference)
−0.40 (−0.47, −0.33) ,0.001 −0.41 (−0.49, −0.33) ,0.001 −0.40 (−0.48, −0.33) ,0.001
Biomass as primary source of fuel −0.22 (−0.30, −0.13) ,0.001 −0.17 (−0.26, −0.08) ,0.001 −0.18 (−0.27, −0.09) ,0.001
Abbreviation: ses, socioeconomic status.
such as lower limit of normal cutoffs.28 While previous 
studies have shown a similar relationship, this analysis is 
unique in that we use a composite index combining multiple 
SES predictors after controlling for important environmental 
exposures in a large population-based sample of individuals 
from LMICs.10 Since SES is a complex measure of a com-
bination of variables, single variables such as education and 
household income may not have the discriminatory power 
to make accurate predictions.
Our analysis also has some potential shortcomings. First, 
we were unable to adjust for occupation, which could influ-
ence the association between SES and COPD. While income 
level and certain occupations correspond, some occupations 
may pose a risk to getting COPD that is not adjusted for when 
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excluded. Second, monthly household income was collected 
as six categories, which may not be perfectly standardized 
and comparable among countries. Third, the GLI reference 
population used to obtain Z-scores in COPD diagnosis may 
not perfectly represent the populations used in this study. 
However, models were run using Caucasian values that 
showed almost identical results. While this does point to 
a robust method of diagnosis, further research is needed to 
investigate variation in results when using other GLI refer-
ence groups. Fourth, we used self-report of daily biomass fuel 
smoke exposure and did not measure personal or household 
pollutant exposures in all participating households. However, 
in previous research, we have found that self-report of daily 
biomass fuel smoke exposure was a good proxy for high vs 
low levels of exposure.29,30
The large sample size, across ten diverse sites including 
ranges of altitude and degree of urbanization, is a fundamen-
tal strength of this study. We used the same definitions for 
SES variables, used similar spirometer devices from the same 
manufacturer (ndd Medical Technologies), all studies were 
population-based with similar methods of screening, and 
data collections occurred during concurrent time periods.16–18 
Furthermore, we used several SES indicators to establish a 
composite, more robust SES index. Combining household 
size, education, and household monthly income into a 
composite SES index likely accounted for income variability 
across sites. We controlled for daily smoking and biomass 
fuel smoke exposure, showing that SES is associated with 
having COPD above and beyond important environmental 
exposures. Finally, the study utilized lower limit of normal to 
diagnose COPD at each site as opposed to a fixed FEV
1
/FVC 
ratio utilized in previous studies. Utilization of lower limit 
of normal likely prevents overdiagnosis of COPD among the 
elderly where natural lung decline may be confounded with 
obstructive lung disease.1,31
Through analysis of a large pooled database from mul-
tiple LMICs, we found that SES was associated with COPD 
and lower lung function. Specifically, this study shows that 
participants of lower SES levels were more likely to have 
COPD and lower FEV
1
/FVC values for their age, using the 
lower limit of normal, which is currently recommended 
by international respiratory societies. The implications 
of the link between SES and disease are broader beyond 
COPD.32 For example, recently biochemical and genetic 
pathways have been identified showing that SES stressors 
result in DNA methylation and molecular genetic mecha-
nisms, which in turn result in a host of inflammatory and 
chronic diseases.33,34 Although SES consists of a range of 
environmental exposures, this evidence suggests that the 
association with disease may be mediated by social and 
Figure 5 absolute difference in pre-bronchodilator FeV1/FVC Z-score by socioeconomic status composite index (ses index), secondary education or higher (below 
secondary as reference), greater than or equal to household size of 4 (below as reference), and monthly household income (change per category).
Notes: We display adjusted differences in pre-bronchodilator FeV1/FVC Z-score for the overall sample (left) and for individual sites (right). In the left panel, the square represents 
the adjusted odds ratio and the segments represent 95% CIs. In the right panel, the triangles represent site-specific adjusted odds ratios. For the composite SES index, we 
calculate the interquartile adjusted difference in pre-bronchodilator FeV1/FVC Z-score, ie, the difference between the 75th and 25th percentiles of the composite ses index.
Abbreviation: ses, socioeconomic status.





psychological stress. Our findings validate prior assumptions 
and findings that point to a relationship between SES and 
COPD and support efforts toward LMIC disease burden and 
priority setting in the global health agendas. Government 
policies aimed at disparities in SES among high-risk groups, 
such as campaigns to use cleaner fuels and guidelines for 
occupational safety, can occur at systems-based level. At an 
individual level, microenterprise and social entrepreneurship 
may serve as additional public health interventions beyond 
tobacco cessation. While global inequality has greatly 
reduced over the past 30 years, inequity within many LMICs 
is on the rise.35 SES will continue to be a risk factor, which 
must be addressed in any public health effort to decrease the 
burden of COPD.
Conclusion
In this analysis of multiple population-based studies, we 
found that lower SES was associated with higher odds of 
having COPD. Since income may be underestimated in study 
populations, composite scores including household size and 
education may be better proxies of SES for our analyses. 
Overall, the relationship between COPD and SES across 
five LMICs with varying disease burden was highlighted to 
guide future investigations and implement interventions to 
reduce the burden of COPD.
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